Save up -80% on Asenapine | |||
Note: this is a drug discount program, not an insurance plan. | |||
RX BIN: 015558 | RX PCN: HT | Group ID: DDN6600 | Card Holder ID: DDN6600 |
Pharmacists and Patients support. |
2019 Price of Saphris | |
$619 | 30 orally disintegrating tabs/10 mg |
price without discount in nearest pharmacy. Price may vary. |
Claim your free Asenapine discount card
We offer free Saphris coupons and discounts that may help you save up to 80% off the retail price in your local pharmacy. Just print your coupon! It’s ready to use and never expire. Present your manufacturer copay card in most local pharmacies to get a discount on Asenapine every time. What are you waiting for? Claim your prescription drug card now!







Get your Prescription

It’s safe and free

Buy drugs in pharmacy

Save money each time
Asenapine volume of distribution
Asenapine is rapidly distributed and has a large volume of distribution (approximately 20 – 25 L/kg), indicating extensive extravascular distribution.

About RX24Drugs
2018 Statistics

Discount Cards 16,000+

Clients Benefit 29%

Total savings $4,735,080
What is Asenapine
Developed by Schering-Plough after its merger with Organon International, asenapine is a sublingually administered, atypical antipsychotic for treatment of schizophrenia and acute mania associated with bipolar disorder. Asenapine also belongs to the dibenzo-oxepino pyrrole class. It is also for severe post-traumatic stress disorder nightmares in soldiers as an off-label use. FDA approved on August 13, 2009.
Asenapine mechanism of action
Asenapine is an atypical antipsychotic multireceptor neuroleptic drug which shows strong 5HT2A (serotonin) and D2 (dopamine) receptor antagonism, which has been shown to enhance dopamine (DA) and acetylcholine (Ach) efflux in rat brains. Asenapine may improve cognitive function and negative symptoms in patients with schizophrenia.
Dosage forms of Asenapine
Form | Route | Strength |
Tablet | sublingual | 10 mg/1 |
Tablet | sublingual | 10 mg |
Tablet | sublingual | 2.5 mg/1 |
Prescription Generics
false
International Brands
Saphris
Synonyms
Saphris
Manufacturers
STAT Rx USA LLC
CAS number
65576-45-6
UNII
JKZ19V908O
State
solid
Affected organisms
Humans and other mammals
Indication of Asenapine
Used for treatment in psychosis, schizophrenia and schizoaffective disorders, manic disorders, and bipolar disorders as monotherapy or in combination.
Toxicity of Asenapine
In patients with schizophrenia, asenapine (in sublingual dosages of 5, 10, 15, or 20 mg twice daily) was associated with relatively small increases in the corrected QT (QTc) interval of 2-5 msec compared with placebo in a controlled and dedicated QT study; these increases were slightly lower than those observed in patients receiving quetiapine. None of the asenapine-treated patients in this study experienced a QTc-interval prolongation of 60 msec or greater compared with baseline, nor did any patient experience a QTc interval of 500 msec or greater. During short-term clinical trials in patients receiving 5 or 10 mg of asenapine sublingually twice daily, post-baseline QT-interval prolongation exceeding 500 msec was reported at similar rates for asenapine and placebo.
RX24 Drugs Disclaimer: consult your healthcare provider before buying a Asenapine on prescription or using an RX manufacturer savings coupon. Content on this page is provided for informational purposes only. Any use of this information is at your own risk.
Get lower price on Asenapine now!
What is Saphris?
Saphris is an antipsychotic drug. It works by changing the actions of chemicals in the brain. Saphris sublingual tablets are used to treat schizophrenia in adults and bipolar disorder in adults and children who are at least 10 years old.
You should not use Saphris if you are allergic to acenapine, or if you have severe liver disease. Saphris can cause serious neurological problems. Stop taking this medicine and consult a doctor immediately if you have: very hard (hard) muscles, high fever, sweating, confusion, fast or uneven heartbeat, light dizziness, tremors, twitching or uncontrolled movements of your eyes, lips, tongue , face, hands, or feet. Saphris is not approved for use in psychotic conditions associated with dementia. Assenapine may increase the risk of death in elderly people with dementia-related conditions.